Tracon Pharmaceuticals | 10-Q:季度報表
Tracon Pharmaceuticals | 8-K:TRACON Pharmicals公佈2024年第一季度財務業績並提供公司最新情況
Tracon Pharmaceuticals | 3:首次持股聲明-高管 Lazar David E.
Tracon Pharmaceuticals | 8-K:重大事件
Tracon Pharmaceuticals | S-1:證券上市註冊聲明
Tracon Pharmaceuticals | 8-K:重大事件
Tracon Pharmaceuticals | 424B5:募資說明書
Tracon Pharmaceuticals | 8-K:重大事件
Tracon Pharmaceuticals | 8-K:重大事件
Tracon Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Ikarian Capital, LLC(5.9%),Neil Shahrestani(5.9%)
Tracon Pharmaceuticals | 8-K:重大事件
Tracon Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-WAYNE AARONSON(2.3%)
Tracon Pharmaceuticals | 4:持股變動聲明-高管 Brown Scott B.
Tracon Pharmaceuticals | 4:持股變動聲明-高管 THEUER CHARLES
Tracon Pharmaceuticals | S-8:員工福利計劃證券登記
Tracon Pharmaceuticals | 10-K:年度報表
Tracon Pharmaceuticals | 8-K:TRACON Pharmicals公佈2023年第四季度和年終財務業績並提供公司最新情況
Tracon Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Lincoln Park Capital Fund, LLC(0.375%),Lincoln Park Capital, LLC(0.375%)等
Tracon Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Opaleye Management Inc.(0.00%)
Tracon Pharmaceuticals | 8-K:重大事件
暫無數據